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Tumor necrosis factor alpha (TNF-a) is a candidate human immunodeficiency virus type 1-induced neu-
rotoxin that contributes to the pathogenesis of AIDS dementia complex. We report here on the effects of
exogenous TNF-a on SK-N-MC human neuroblastoma cells differentiated to a neuronal phenotype with
retinoic acid. TNF-a caused a dose-dependent loss of viability and a corresponding increase in apoptosis in
differentiated SK-N-MC cells but not in undifferentiated cultures. Importantly, intracellular signalling via
TNF receptors, as measured by activation of the transcription factor NF-kB, was unaltered by retinoic acid
treatment. Finally, overexpression of bcl-2 or crmA conferred resistance to apoptosis mediated by TNF-a, as did
the addition of the antioxidant N-acetylcysteine. These results suggest that TNF-a induces apoptosis in
neuronal cells by a pathway that involves formation of reactive oxygen intermediates and which can be blocked
by specific genetic interventions.
Until recently it was unknown whether neurons die by ap-
optosis or necrosis during human immunodeficiency virus type
1 (HIV-1) infection of the central nervous system. Studies from
our laboratory using an in situ technique demonstrated that
apoptotic neurons were infrequently observed in cerebral cor-
tex and basal ganglia of pediatric patients that had HIV-1
infection but no evidence of encephalitis or neurologic dys-
function. In contrast, patients who had HIV-1 encephalitis and
neurologic dysfunction had up to 30% of neurons with apop-
totic nuclei in proximity to perivascular infiltrates of HIV-1-
infected macrophages and reactive microglia in cerebral cortex
and basal ganglia (14). Because only latent infection of neu-
rons by HIV-1 has been demonstrated in a single postmortem
case (40), these findings suggest that HIV-1-induced diffus-
ible factors may mediate neuronal apoptosis in HIV-1 en-
cephalitis.
A plausible explanation for how HIV-1 causes neuronal
dysfunction and cell loss when only a small number of brain
microglia and macrophages support productive viral infection
is production of soluble neurotoxic factors from HIV-1-in-
fected macrophages and microglia (16, 18, 19). Neuronal death
can occur after exposure of neurons to supernatants from
HIV-1-infected monocytes or monocytoid cell lines or during
cell-to-cell contact of virus-infected monocytes and astro-
glioma cells (16, 18, 19). The most widely studied gene product
of HIV-1 is the envelope protein gp120. In picomolar amounts,
in the presence of sublethal concentrations of glutamate, it has
been shown to be neurotoxic to rat retinal ganglion cells in
vitro (8, 29). However, gp120-induced neurotoxicity disap-
peared when neuronal cultures were depleted of macrophages
(27, 28). Giulian et al. (20) have shown that gp120 can activate
purified cultures of rat microglia to produce a low-molecular-
weight neurotoxin that activates N-methyl-D-aspartate recep-
tors and results in neuronal loss. These findings suggest that
gp120 may not be directly toxic to neurons but rather may
activate either HIV-1-infected or uninfected macrophages or
microglia in the brain to kill neurons through an excitotoxic
mechanism. Lethal excitotoxic damage to neurons from over-
stimulation of N-methyl-D-aspartate receptors by the neuro-
transmitter glutamate has been implicated in the neuropatho-
genesis of AIDS (9, 29). In vitro models suggest that chronic
exposure to glutamate can result in neuronal apoptosis (41,
42).
Indeed, gp120 is not the only neurotoxic factor produced by
HIV-1 infection of macrophages or microglia. Genis et al. (18)
demonstrated that HIV-1-infected macrophages could be ac-
tivated by coculture with astrocytoma cells to produce neuro-
toxic factors. Conditioned medium from such macrophages has
been shown to contain high levels of the cytokine tumor ne-
crosis factor alpha (TNF-a), as well as platelet-activating factor
(PAF) and various arachidonic acid metabolites. PAF is in fact
a regulator of TNF-a biosynthesis (49), and both PAF and
TNF-a have been shown to be neurotoxic to cultured human
fetal neurons at physiologically relevant concentrations (13,
16). Importantly, mRNA for TNF-a is present at higher levels
in the brains of patients with HIV-1 associated dementia than
in brains of patients with HIV-1 infection but without demen-
tia (50). These studies strongly suggest that TNF-a may play
a major role in the pathogenesis of HIV-1-associated de-
mentia.
TNF-a has been well characterized as a mediator of oxida-
tive stress. TNF-a stimulates the production of reactive oxida-
tive intermediates (ROIs) in T cells (26, 33). TNF-a-mediated
* Corresponding author. Mailing address: Division of Pediatric Neu-
rology, Box 631, University of Rochester Medical Center, 601 Elm-
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oxidative stress, in turn, produces apoptosis in nonneural cells
(5, 32). This has been proposed as a mechanism for depletion
of CD41 T cells in AIDS (1, 21). Because TNF-a acts in a
neurotoxic fashion in primary human neuronal cultures and
apoptotic neurons have been identified in the brains of patients
with HIV-1 encephalitis and dementia, we sought to determine
whether TNF-a could induce apoptosis in neuronal cells. In
this report, we describe the ability of TNF-a to induce apop-
tosis and loss of viability in a dose-dependent fashion in the
human neuroblastoma cell line SK-N-MC if cells were first
differentiated to a neuronal phenotype by using retinoic acid
(RA); undifferentiated SK-N-MC cells were not killed by
TNF-a. We further demonstrate that ROIs are required for
TNF-a-mediated neuronal apoptosis, since cell death can be
blocked by the antioxidant N-acetylcysteine (NAC). Finally, we
show that overproduction of specific antiapoptotic gene prod-
ucts (encoded by bcl-2 and crmA) can protect neuronal cells
from the TNF-a-mediated cytotoxocity.
MATERIALS AND METHODS
Cell culture. Human neuroblastoma SK-N-MC cells were obtained from the
American Tissue Culture Collection (3) and cultured in plastic tissue culture
dishes (Corning) without any additional substrates. Cells were grown in a hu-
midified incubator at 378C with a 5% CO2–95% air atmosphere. Cells were fed
every 2 days with complete minimal essential medium and differentiated to a
neuronal phenotype, as necessary, by addition of 5 mM RA (Sigma, St. Louis,
Mo.) for 4 to 5 days (this results in morphologic changes, which include the
development of neuritic processes, as well as the expression of neuronal mark-
ers).
SK-N-MC subclones. To establish SK-N-MC cell lines that overexpress crmA
and bcl-2, pJ415 and pJ436 (gift of J. Yuan) (35) were transfected into the
amphotropic retroviral packaging cell line PA317 (American Type Culture Col-
lection) (34) by using the Lipofectamine reagent (Gibco/BRL); the control
vector pBabePuro (gift of H. Land) (36) was likewise transfected into PA317
cells. Supernatant from transiently transfected PA317 cells was used to infect
SK-N-MC cells overnight, and resistant cells were then selected in 5 mg of
puromycin per ml for approximately 20 days. Resistant colonies were cloned and
checked for expression levels by using Western blots (immunoblots). In gene-
modified populations of SK-N-MC cells (bcl-2 or crmA), cells stopped growing
within 1 day of RA treatment. Neuronal morphology was also observed with RA
treatment.
HIV-1 infection of monocytes and preparation of conditioned media. Mono-
cytes were recovered from peripheral blood mononuclear cells of HIV- and
hepatitis B-seronegative donors after leukapheresis and purified by countercur-
rent centrifugal elutriation as previously described (18). Cells were cultured as
adherent monolayers (106 cells per ml in 24-mm-diameter plastic culture wells)
in Dulbecco modified Eagle medium (Sigma) with recombinant human macro-
phage colony-stimulating factor (Genetics Institute, Inc., Cambridge, Mass.)
(17). The human brain astroglia tumor-derived cell line U251 MG was used in
cocultivation assays with HIV-1-infected monocytes as described previously (18).
These cells were grown as adherent monolayers in Dulbecco modified Eagle
medium (Sigma) supplemented with 10% heat-inactivated fetal calf serum (Sig-
ma) and 50 mg of gentamicin per ml.
Monocytes were exposed to HIV-1ADA (GenBank accession number M60472)
(38) at a multiplicity of infection of 0.01 infectious virion per target cell as
previously described (17). The viral inocula were free of mycoplasma contami-
nation (Mycoplasma Detection Kit III; Geneprobe, San Diego, Calif.). Macro-
phage colony-stimulating factor-treated monocytes were cultured as adherent
monolayers 7 to 10 days prior to use as viral target cells. Under these conditions,
10 to 20% of the monocytes were infected 7 days after HIV-1 inoculation, as
determined by immunofluorescence and in situ hybridization techniques (22). All
cultures were refed with fresh medium every 2 to 3 days. Reverse transcriptase
activity for HIV-1 was determined in culture fluids as previously described (22).
Five to seven days after infection and during the peak of reverse transcriptase
activity (107 cpm/ml) in HIV-1-infected monocytes, equal numbers of astroglial
U251 MG cells were added, and the medium was analyzed for TNF-a by enzyme-
linked immunosorbent assay (ELISA) as previously described (18).
Apoptosis assays and TUNEL immunostaining. The ApopTag peroxidase
assay kit (ONCOR, Gaithersburg, Md.) was used to detect free 39-OH ends of
newly cleavedDNA in situ. In this method, called TUNEL (terminal deoxynucleo-
tidyltransferase end labeling), digoxigenin-dUTP is added to 39-OH ends of
double- and single-stranded DNA by terminal deoxynucleotidyltransferase. An
antidigoxigenin Fab antibody with conjugated peroxidase is then used to immu-
nostain nuclei that have high concentrations of 39-OH ends of cleaved DNA.
Because the ApopTag antidigoxigenin antibody has no Fc portion and has less
than 1% cross-reactivity with other endogenous steroids, nonspecific binding is
very low.
Parallel sections from SK-N-MC cell cultures grown on poly-L-lysine-coated
coverslips were counterstained with methyl green (0.5% [wt/vol] in 0.1 M sodium
acetate [pH 4.0]) to label cells with intact nuclear DNA. All experiments with
ApopTag reagent included a positive control (control neuronal SK-N-MC cells)
that was incubated with endonuclease prior to assay (DNase I; 0.0002 U/ml;
Promega, Madison, Wis.). This treatment nicks DNA in all cells and gives
uniformly positive nuclear staining in all cell types present.
Digitized images of ApopTag-stained neuronal SK-N-MC cells in $15 micro-
scopic fields were analyzed for numbers of positively stained nuclei per 503 field
by using a densitometer (Imaging Research Inc., Ontario, Canada). Data were
expressed as mean of positive nuclei 6 standard error of the mean. Tests of
statistical significance between control and experimental treatments were deter-
mined by paired t tests.
Acridine orange staining. Cell suspensions (106 cells per ml) of either vehicle
(medium alone) or TNF-a (1 ng/ml [final concentration], 48 h) were mixed with
acridine orange (100 mg/ml; Sigma) at a ratio of 1:25, placed on a microscope
slide, coverslipped, and examined by fluorescence microscopy, using a 403 dry
objective. Representative fields were photographed to examine morphologic
changes indicative of apoptosis.
Gel electrophoresis of low-molecular-weight DNA. SK-N-MC cells treated
with either vehicle (medium) or TNF-a (2 ng/ml [final concentration], 48 h) were
harvested mechanically and lysed in 0.5 ml of 0.5% Triton X-100–5 mM Tris (pH
7.4)–5 mM EDTA at 48C for 20 min. The suspension was then centrifuged at
27,000 3 g for 15 min in an SW50.1 rotor (Beckman); the supernatant was
extracted repeatedly with phenol-chloroform and precipitated in ethanol. The
precipitates were resuspended in 10 mM Tris–1 mM EDTA, digested in 0.5 mg
of boiled RNase A per ml for 1 h at 378C, and submitted to electrophoresis
through 1.8% agarose followed by staining with ethidium bromide.
Cytotoxicity assays. 3-(4,5-Dimethylthiazol-2 yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) assays were performed by a modification of the method of Mosman
(37). Briefly, viability of SK-N-MC cells grown in 96-well plates is determined by
conversion of MTT (Sigma). ReducedMTT is solubilized with dimethyl sulfoxide
as instructed by the manufacturer, and the color intensity is measured at 490 nm
with an ELISA reader. In some experiments, cell viability was also assayed with
SK-N-MC cell cultures containing a 0.4% solution of trypan blue, with blue
(nonviable) cells and cells excluding trypan blue counted in a hemocytometer
under phase-contrast microscopy.
Antibodies and immunochemistry. Cell surface levels of TNF receptor
(CD120a or TR55) were assessed on SK-N-MC sublines by flow cytometry, using
a murine anti-human TR55 monoclonal antibody (clone M50; Genzyme). Flow
cytometric analysis was performed with a Becton Dickinson FACScan with Lysis
II software or an EPICS PROFILE flow cytometer. Cellular expression of bcl-2
was determined by using a rabbit polyclonal antiserum (Pharmingen); expression
of crmA was detected with a rabbit polyclonal antiserum (gift of J. Yuan) by
Western blotting procedures (ECL system; Amersham).
Analysis of NF-kB activation. SK-N-MC cells were grown on six-well plates
and were transfected with plasmid DNAs [p(kB)3conaLUC and pGDMAD3 (3,
38, 46)] by using the Lipofectamine reagent (Gibco/BRL). Briefly, 2 mg of DNA
plus 8 ml of Lipofectamine, in medium, was added to each well. Cells were then
incubated for 5 h at 378C, after which the medium was aspirated and replaced
with fresh medium containing either RA (5 mM) or dimethylsulfoxide alone
(vehicle). After 60 h, cells were harvested for luciferase assays. Twenty-four
hours prior to harvest (36 h after addition of RA), exogenous TNF-a (Genzyme)
was added to selected cultures at a final concentration of 10 ng/ml. All transfec-
tions were performed in triplicate, and cell lysates were assayed for luciferase
activity by using commercially available reagents (Promega) in an LKB series
1250 luminometer.
RESULTS
Initial experiments demonstrated that conditioned media
from HIV-infected macrophages, activated by coculture with
astroglial cells to produce levels of TNF-a that ranged between
2 and 6 ng/ml (17), were neurotoxic to cultures of SK-N-MC
cells differentiated to a neuronal phenotype with 1.5 mM RA
(Fig. 1). After a 48-h exposure to conditioned medium from
HIV-1-infected macrophages cocultured with astroglial cells,
SK-N-MC neuronal cultures had a 50% decrease in viability
determined by the MTT assay relative to medium control cul-
tures. In contrast, conditioned medium from uninfected mac-
rophages (Fig. 1), uninfected macrophages cocultured with
astroglial cells, or HIV-1-infected macrophages alone (data
not shown) had no significant effect on SK-N-MC neuronal cell
viability.
Because recombinant human TNF-a is neurotoxic to human
fetal cortical neuronal cultures in a dose-dependent fashion
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(13), we investigated whether TNF-a was toxic to undifferen-
tiated (nonneuronal) or differentiated (neuronal) SK-N-MC
cell cultures. Viability of undifferentiated SK-N-MC cells was
unaffected after a 48-h exposure to doses of TNF-a of up to 10
ng/ml (Fig. 2). In contrast, neuronal SK-N-MC cultures had a
dose-dependent decrease in viability.
Having established that TNF-a was toxic to neuronally dif-
ferentiated SK-N-MC cells but not to control cells, we wished
to determine the mechanism of TNF-a-mediated cell death.
Previous studies have shown that TNF-a triggers apoptosis on
nonneural cells (5, 32). We therefore examined whether expo-
sure of neuronal SK-N-MC cells to TNF-a likewise resulted in
apoptosis. TNF-a, at a dose of 2 ng/ml for 48 h, resulted in
fragmentation of DNA into a 180- to 200-bp ladder resolved by
gel electrophoresis (Fig. 3C). Exposure of neuronal SK-N-MC
cells to vehicle did not cause any demonstrable DNA laddering
(Fig. 3C). Exposure of neuronal SK-N-MC cells to 1 ng of
TNF-a per ml for 24 h, followed by staining of trypsinized cells
with the fluorescent DNA-binding dye acridine orange, re-
vealed morphologic hallmarks of apoptosis, including chroma-
tin condensation and membrane blebbing (Fig. 3B). In con-
trast, neuronal SK-N-MC cells exposed to vehicle for 24 h had
evidence of intact chromatin structure, as demonstrated by
acridine orange staining, without evidence of crescentic chro-
matin, spherical beading of chromatin, or membrane blebbing
(Fig. 3A).
To determine the time course of apoptosis in neuronal SK-
N-MC cell cultures exposed to 0.2 ng of TNF-a per ml, we used
TUNEL staining of free 39-OH ends of cellular DNA to iden-
tify cells in situ with large amounts of fragmented nuclear
DNA (i.e., apoptotic nuclei). Using this method, we detected
significant numbers of apoptotic nuclei in neuronal SK-N-MC
cell cultures 8 h (but not 1 or 4 h) after application of 0.2 ng of
TNF-a per ml which increased to a maximum by 48 h after
exposure (data not shown). We therefore examined the rela-
tionship between neurotoxicity and number of apoptotic nuclei
in neuronal SK-N-MC cell cultures exposed to increasing doses
of TNF-a for 48 h. Figures 4A and B demonstrate an inverse
proportional relationship between dose-dependent loss of via-
bility measured by the MTT (Fig. 4A) assay and trypan blue
exclusion (Fig. 4B) and increasing doses of TNF-a ranging
from 0.05 to 100 ng/ml in neuronal SK-N-MC cells. Figure 4C
demonstrates a direct proportional relationship between in-
creasing number of apoptotic nuclei and increasing doses of
TNF-a ranging from 0.05 to 25 ng/ml in neuronal SK-N-MC
cells. Figure 5 shows neuronal SK-N-MC cells TUNEL stained
to demonstrate fragmented nuclear DNA. Even at low doses of
TNF-a (0.05 [Fig. 5B] and 0.2 [Fig. 5C] ng/ml), significant
numbers of nuclei are TUNEL stained. Using the TUNEL
method, we observed no labeling in neuronal SK-N-MC cul-
tures exposed to vehicle for 48 h (Fig. 4A).
TNF-a has been shown to mediate intracellular signals at
least in part via the generation of ROIs (45), which have
themselves been shown to be neurotoxic (23). Thus, we exam-
ined whether the antioxidant NAC would prevent TNF-a-me-
diated cytolysis of neuronal SK-N-MC cells (Fig. 6). NAC at a
dose of 0.5 mM completely blocked TNF-a-mediated cytotox-
icity at doses up to 20 ng/ml when coapplied to neuronal
SK-N-MC cell cultures, as measured by the MTT assay. These
results were also confirmed when measured by trypan blue
exclusion (data not shown).
We also wished to determine whether known inhibitors of
apoptosis could likewise block TNF-a-mediated neurotoxicity.
Perhaps the best studied antiapoptotic gene is bcl-2, which has
been shown to prevent apoptosis in several neural cell lines in
response to a wide variety of stimuli, including agents that
promote formation of free radicals (23). Accordingly, we over-
expressed bcl-2 in SK-N-MC cells using a retroviral vector (35)
FIG. 1. Conditioned medium from HIV-1-infected monocytes, grown in the
presence of astroglioma cells, is toxic to RA-treated SK-N-MC cells. Conditioned
medium was prepared as described in Materials and Methods and applied for 48
h (1:10 [vol/vol]) to cultures of SK-N-MC cells grown to ;75% confluence prior
to treatment with 5 mM RA. Conditioned medium from HIV-1-infected macro-
phages was obtained after 24 h of coculture of HIV-1-infected macrophages (7
days after HIV-1 infection) with U251 astroglial cells. After 48 h, SK-N-MC cells
were observed for morphologic changes, then medium was removed, and cell
viability of adherent SK-N-MC cells was determined by the MTT assay (eight
replicates per condition). Values shown are means from a single representative
experiment (this experiment was repeated two times, with similar results); the
standard errors of mean values are marked by bars, and statistical significance
(indicated by the asterisk) was taken at the P , 0.01 level. OD490 nm, optical
density at 490 nm.
FIG. 2. Dose-dependent toxicity of TNF-a for neuronally differentiated SK-
N-MC cells but not control cells. Cultures of SK-N-MC cells were grown in
96-well plates for 2 days and then treated with either medium alone or medium
containing 5 mM RA for 4 days prior to treatment with increasing doses of
TNF-a for 48 h. MTT assays were performed as described in Materials and
Methods (eight replicates per datum point). Values shown are means values
from a single representative experiment (this experiment was repeated two times,
with similar results); the standard errors of mean values are marked by bars, and
statistical significance (indicated by asterisks) was taken at the P , 0.01 level.
OD490 nm, optical density at 490 nm.
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and then measured TNF-a-mediated neurotoxicity. As antici-
pated, the cytolytic effects of TNF-a were completely abro-
gated in a bulk population of bcl-2-expressing neuronal SK-
N-MC cells (Fig. 7B). We also derived a clonal subpopulation
of SK-N-MC cells which expressed high levels of crmA, which
is a cowpox virus gene product that has also been shown to
prevent apoptosis in neural cells (11), presumably by suppress-
ing the activity of interleukin 1b-converting enzyme (35).
Again, TNF-a, at doses up to 12.5 ng/ml for 48 h, was not toxic
to neuronal SK-N-MC cells that expressed high levels of crmA
(Fig. 7B).
One explanation for the observation that TNF-a is toxic only
to neuronal SK-N-MC cells, not to undifferentiated cells, is
that the cellular differentiation triggered by RA is associated
with an increase in TNF receptors or an alteration in receptor-
mediated signalling pathways. To address these questions, we
first determined by flow cytometry whether RA treatment led
to elevated expression of the p55 TNF receptor, which is
largely responsible for the cytotoxic properties of TNF-a (2,
47). No change was seen in the cell surface level of p55 recep-
tors in the undifferentiated (non-RA-treated) versus the dif-
ferentiated (neuronal; RA-treated) SK-N-MC cells (data not
shown). We also determined whether RA treatment resulted in
a perturbation of TNF signalling in SK-N-MC cells by mea-
suring one of the downstream products of TNF receptor-me-
diated stimulation. Thus, we performed transient transfection
analyses to quantitatively assess the activation of the cellular
transcription factor NF-kB in TNF-a-treated SK-N-MC cells.
To do this, SK-N-MC cells were transfected with an NF-kB
responsive luciferase reporter plasmid [p(kB)3conaLUC (38)]
together with an equimolar amount of either pUC19 plasmid
DNA or an expression construct which encodes a specific in-
hibitor of NF-kB, IkBa (pGDMAD3 [46]). As expected,
TNF-a stimulation of SK-N-MC cells resulted in a greatly (17-
to 18-fold) elevated level of luciferase expression from
p(kB)3conaLUC (Fig. 8). TNF-a-dependent enhancement of
luciferase expression was equally pronounced in both RA-
treated and non-RA-treated SK-N-MC cells (Fig. 8). Finally,
this effect of TNF-a was shown to be due to activation of
NF-kB since it was inhibited by coexpression of IkBa (Fig. 8).
Thus, differentiation of SK-N-MC cells with RA does not
change the relative extent of NF-kB activation in response to
TNF-a. These results suggest that TNF-a-mediated neurotox-
icity and apoptosis are due not to augmented signal transduc-
tion through TNF receptors but rather to an altered response
of differentiated neuronal cells to such signalling compared
with their undifferentiated counterparts.
DISCUSSION
The mechanism(s) by which neurons die in HIV-1 enceph-
alitis remains unclear. Latent infection of neurons by HIV-1
has been reported in only one study (40) and thus remains an
unlikely mechanism by which neurons die. However, many
candidate neurotoxins produced by direct or indirect interac-
tions between host cells have been studied. These neurotoxins,
either by themselves or in combination with the neurotrans-
mitter glutamate, have been shown to be neurotoxic to neurons
in in vitro culture systems. These include the HIV-1 gene
products gp120 (8, 29) and Tat (24, 25), leukotrienes and
lipoxins (18), PAF (16, 18), and TNF-a (13). We have previ-
ously shown that TNF-a alone or in combination with an
AMPA receptor agonist is neurotoxic to human fetal cortical
neurons in primary cultures (13). In that report, electron mi-
croscopic studies of human fetal neurons exposed to low (0.2-
ng/ml) doses of TNF-a were suggestive but not conclusive of
some features of apoptosis (chromatin condensation). How-
ever, it has remained unclear whether TNF-a induces cell
death by binding and activation of p55 or p75 receptors ex-
pressed on neurons or indirectly through receptors located on
FIG. 3. TNF-a induces nuclear condensation in neuronally differentiated SK-N-MC cells. (A) SK-N-MC cells grown for 4 days in the presence of 5 mMRA, treated
with medium containing RA for an additional 48 h, trypsinized, stained with acridine orange, and then examined by fluorescence microscopy using a 403 dry objective.
(B) SK-N-MC cells grown for 4 days in the presence of 5 mMRA, treated with TNF-a (1 ng/ml) containing RA for an additional 48 h, trypsinized, stained with acridine
orange, and then examined by fluorescence microscopy using a 403 dry objective. Note condensed chromatin and membrane blebbing, morphologic hallmarks of
apoptosis. (C) Gel electrophoresis of low-molecular-weight DNA of SK-N-MC cells grown for 4 days in the presence of 5 mM RA and then treated with medium
containing RA for an additional 48 h (lane 2), exposed to UV light for 20 min and then returned to the incubator for 6 h (lane 3, positive control for apoptosis), or
treated with TNF-a (1 ng/ml) containing RA for an additional 48 h (lane 4). Marker lanes 1 and 5 are l/HindIII and fX/HaeIII, respectively.
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glial cells or cells of macrophage lineage. Because TNF-a in-
duces apoptosis in nonneural cells (5, 32), we investigated
whether TNF-a induces apoptosis in human neuronal cells.
The human neuroblastoma SK-N-MC cell line was chosen in
part to determine whether TNF-a is directly neurotoxic to
human neuronal cells, since neuronal SK-N-MC cells lack glu-
tamate receptor subtypes (15).
Conditioned medium from HIV-1-infected macrophages ac-
tivated by coculture with astroglial cells contains TNF-a at
levels in the nanograms-per milliliter range (18) and is neuro-
toxic to differentiated (neuronal) SK-N-MC cells (Fig. 1). In
contrast, conditioned medium from uninfected macrophages,
uninfected macrophages cocultured with astroglial cells, or
HIV-1-infected macrophages alone contains roughly 1,000
times less TNF-a (18) and is not neurotoxic to neuronal SK-
N-MC cells (Fig. 1 and data not shown). Although HIV-1-
infected macrophages, activated by coculture with astroglial
cells, express other neurotoxic substances, including PAF, that
may induce apoptosis in neuronal cells (data not shown), we
focused on TNF-a’s ability to induce apoptosis in neuronal
cells for the following reasons: activated HIV-1-infected mac-
rophage expression of TNF-a is correlated with neurotoxicity
in primary neuronal cultures (13, 18), and levels of mRNA for
TNF-a are correlated with dementia in patients with HIV-1
infection of the central nervous system (50).
Our data show that TNF-a is toxic to differentiated neuronal
SK-N-MC cultures (Fig. 2) but not to control, undifferentiated,
cells. We therefore investigated whether neuronal cell death
was the result of apoptosis. Gel electrophoresis of low-molec-
ular-weight DNA (Fig. 3C), acridine orange staining of DNA
(Fig. 3A and B), and TUNEL staining of free 39-OH ends of
fragmented DNA (Fig. 5) confirmed by molecular and mor-
phologic criteria that application of TNF-a in doses that
ranged from physiologic (0.05 ng/ml) to pharmacologic (#100
ng/ml) resulted in neuronal apoptosis.
The question remained whether TNF-a could trigger apop-
tosis in neuronal SK-N-MC cells through up-regulation of
TNF-a receptors or alterations in TNF-mediated intracellular
signalling. Clearly, only SK-N-MC cells differentiated to a neu-
ronal phenotype were susceptible to TNF-a-mediated toxicity
(Fig. 2). However, flow cytometry studies demonstrated that
p55 TNF receptors were not up-regulated in neuronal SK-
N-MC cells. Likewise, the relative magnitudes of TNF-a-me-
diated NF-kB activation in neuronal SK-N-MC cells and their
undifferentiated counterparts were equivalent (Fig. 8). These
results suggest that the neuronal SK-N-MC cell is susceptible
to TNF-a-mediated programmed cell death because it is ter-
minally differentiated, not because TNF-a-mediated signal
transduction is augmented in neuronal cells.
In nonneural cells, application of TNF-a results in increased
intracellular levels of ROIs (26, 33) which have been associ-
ated with oxidative stress-induced apoptosis. Since the thiol
antioxidant NAC was able to prevent TNF-a-mediated neuro-
toxicity (Fig. 6), it is likely that increased formation, or de-
creased scavenging, of ROIs is important in initiating apoptosis
in neuronal SK-N-MC cells exposed to TNF-a (5).
FIG. 4. TNF-a-mediated cytolysis in neuronally differentiated SK-N-MC
cells is dose dependent and associated with an increase in apoptosis. (A) Dose-
dependent decrease in viability, as measured by the MTT assay, for SK-N-MC
cells grown for 4 days in the presence of 5 mM RA and then treated with TNF-a
(0.05 to 100 ng/ml). (B) Dose-dependent decrease in viability, as measured by the
trypan blue dye exclusion assay, for SK-N-MC cells grown for 4 days in the
presence of 5 mM RA and then treated with TNF-a (0.05 to 100 ng/ml). (C)
Dose-dependent increase in apoptotic nuclei, identified by TUNEL staining, for
SK-N-MC cells grown for 4 days in the presence of 5 mM RA and then treated
with TNF-a (0.05 to 25 ng/ml) for an additional 48 h. All assays were performed
as described in Materials and Methods (eight replicates per datum point). Values
shown are means from a single representative experiment (experiments were
repeated two times, with similar results); the standard errors of mean values are
marked by bars, and statistical significance (indicated by asterisks) was taken at
the P , 0.01 level. OD490 nm, optical density at 490 nm.
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The finding that overexpression of bcl-2 or crmA in neuronal
SK-N-MC subclones was able to completely prevent TNF-a-
mediated neurotoxicity (Fig. 7) confirms that TNF-a leads to
neuronal cell death via an apoptotic pathway. It is noteworthy
that bcl-2 can also prevent necrotic cell death mediated by
glutathione depletion in at least one neural cell line (23).
FIG. 5. TNF-a causes a dose-dependent increase in apoptosis in neuronally differentiated SK-N-MC cells. (A) TUNEL staining for SK-N-MC cells grown for 4 days
in the presence of 5 mM RA and then treated with vehicle alone for an additional 48 h. (B) TUNEL staining for SK-N-MC cells exposed to TNF-a at a dose of 0.05
ng/ml for 48 h. (C) TUNEL staining for SK-N-MC cells exposed to TNF-a at a dose of 0.2 ng/ml for 48 h.
FIG. 6. TNF-a-mediated killing of neuronally differentiated SK-N-MC cells
is inhibited by addition of antioxidant. MTT assays for cell viability of SK-N-MC
cell cultures grown for 4 days in the presence of 5 mM RA and then treated with
increasing doses of TNF-a in the presence or absence of 500 mM NAC for 48 h
were performed as described in Materials and Methods (eight replicates per
datum point). Values shown are means from a single representative experiment
(this experiment was repeated twice, with similar results); the standard errors of
mean values are marked by bars, and statistical significance (indicated by aster-
isks) was taken at the P , 0.01 level. OD490 nm, optical density at 490 nm.
FIG. 7. Overexpression of bcl-2 and crmA confers resistance to apoptosis
mediated by TNF-a in neuronally differentiated SK-N-MC cells. (A) MTT assay
for cell viability of a bulk population of puromycin-resistant SK-N-MC cells
transduced with the control retroviral vector pBabePuro (see Materials and
Methods). Cells were grown in the presence or absence of 5 mM RA for 4 days
and then exposed to increasing doses of TNF-a. (B) MTT assay for cell viability
of RA-treated SK-N-MC cells which overexpress bcl-2 (bulk population of cells)
or crmA (clonal cell population). In both populations of SK-N-MC cells (bcl-2 or
crmA), cells stopped growing within 1 day of RA treatment. Neuronal morphol-
ogy was also observed with RA treatment. Expression of bcl-2 or crmA was
confirmed by Western blotting (data not shown). Values shown are means from
a single representative experiment performed in triplicate (this experiment was
repeated twice, with similar results); the standard errors of mean values are
marked by bars, and statistical significance (indicated by asterisks) was taken at
the P , 0.01 level. OD490 nm, optical density at 490 nm.
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However, we have shown by TUNEL staining, DNA laddering,
and acridine orange binding that TNF-a-mediated death of
neuronal SK-N-MC cells is apoptotic. Thus, expression of bcl-2
in neuronal SK-N-MC cells is able to prevent programmed cell
death due to TNF-a. Furthermore, since RA treatment in-
duced growth arrest and neuronal morphology in all gene-
modified derivatives of SK-N-MC cells, it is unlikely that
transfection with bcl-2 or crmA prevented TNF-a-mediated
apoptosis by preventing differentiation. These findings are con-
sistent with findings that bcl-2 can prevent TNF-a-mediated
cytotoxicity in HeLa cells (7) and suggest that it may ultimately
be possible to design gene-based strategies to prevent neuronal
loss in AIDS dementia complex and thereby ameliorate or halt
this progressive neurodegenerative disorder. The data do not,
however, reveal the precise molecular basis by which TNF-a
triggers neuronal apoptosis. Although overexpression of crmA
in neuronal SK-N-MC cells was apparently as efficacious as
bcl-2 expression in preventing the dose-dependent cell death
induced by TNF-a, it is unclear whether crmA and bcl-2 affect
the same metabolic pathway, i.e., activation of putative death
genes for interleukin 1b-converting enzyme or Ich-1 (48). Fur-
ther studies will be required to determine the nature and
abundance of pro- and antiapoptotic gene products in TNF-
a-treated neuronal SK-N-MC cells. One possibility is that ter-
minally differentiated SK-N-MC cells are vulnerable to oxida-
tive stress induced by TNF-a and respond by aberrant
activation of cyclin D1 (10).
Interestingly, TNF-mediated neurotoxicity is not seen in
other experimental systems utilizing neuronal cultures. Cheng
et al. demonstrated that pharmacologic doses (10 to 100 ng/ml)
of TNF-a and TNF-b were protective against N-methyl-D-
aspartate-mediated excitotoxicity or glucose deprivation injury
to rat hippocampal neuronal cultures only when cultures were
pretreated 24 h prior to the insult (6). One possible explana-
tion for this apparent discrepancy is that there is a species
difference in response. In previous studies of TNF-a-mediated
neurotoxicity, we used primary human cortical neuronal cul-
tures (13). In the present study, we used a monoclonal cell line
derived from a human neural tumor. Another explanation for
this paradox is that in cellular systems governed by redox
regulation, opposite biological effects can be obtained depend-
ing on the level of oxidant stress. For example, nitric oxide can
both induce and inhibit apoptosis in certain cell types (31, 44).
With respect to HIV-1 encephalitis and neurologic dysfunc-
tion, including progressive encephalopathy in children and de-
mentia in adults, these studies are important for several rea-
sons. First, only latent infection of neurons by HIV-1 has been
demonstrated in a single postmortem case (40); hence, soluble
HIV-induced neurotoxic factors are likely to induce cell death.
Second, levels of mRNA for TNF-a are elevated in brain tissue
of adults who had HIV-1-associated dementia (50). Third,
TNF-a synthesis is markedly elevated in HIV-1-infected mac-
rophages in vitro upon activation of cells via antigenic stimuli
or contact with astroglial cells (18). Fourth, apoptotic neurons
are present at high levels in brain tissues from children who
died with HIV-1 encephalitis and encephalopathy, and these
cells are located in close proximity to HIV-1-infected macro-
phages (14). In the present report, we present a possible ex-
planation for these seemingly disparate observations by show-
ing that TNF-a, a candidate HIV-1-induced neurotoxin, activates
programmed cell death in human neuronal cells. We also dem-
onstrate that this neurotoxicity can be ameliorated by the an-
tioxidant NAC, and we show that overexpression of bcl-2 and
crmA can also block this process. These findings suggest novel
therapeutic approaches to the treatment of neurologic dys-
function in HIV-1 infection of the central nervous system.
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